+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
LALPATHLAB

Dr. Lal Pathlabs Share Price

₹1,934.00 -18.3 (-0.94%)
51.97% Gain from 52W Low

28 Sep, 2026 1:16 PM (IST)

Dr. Lal Pathlabs live price: ₹1,934.00. It opened at ₹1,952 vs previous close ₹1,952; intraday high/low: ₹1,965/₹1,908. The 50 & 200 DMA stand at ₹1,867.40/₹1,667.10.

Dr. Lal Pathlabs Performance

  • Today's Low
  • ₹1,908
  • Today's High
  • ₹1,965
  • 52 Week Low
  • ₹1,273
  • 52 Week High
  • ₹2,039
  • Open Price₹1,952
  • Previous Close₹1,952
  • Volume84,448
  • 50 DMA₹1,867.40
  • 100 DMA₹1,773.90
  • 200 DMA₹1,667.10

Dr. Lal Pathlabs Chart

Investment Returns

  • Over 1 Month -0.12%
  • Over 3 Month + 14.49%
  • Over 6 Month + 45.92%
  • Over 1 Year + 21.08%

Smart Investing Starts Here Start SIP with Dr. Lal Pathlabs for Steady Growth!

Invest Now

Dr. Lal Pathlabs Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 59.9
  • PEG Ratio
  • 10.7
  • Market Cap Cr
  • 32,462
  • P/B Ratio
  • 12.1
  • Average True Range
  • 56.8
  • EPS
  • 32.3
  • Dividend Yield
  • 0.8
  • MACD Signal
  • 14.6
  • RSI
  • 59.55
  • MFI
  • 63.29

Latest Stock News Updates

Dr Lal PathLabs' arm acquires 80% stake in Ghana's Sunshine Healthcare

The acquisition was completed under the agreement and applicable provisions in Ghana, making Sunshine Healthcare a step-down subsidiary of Dr Lal PathLabs.

Broker's call: Dr Lal Pathlabs

Emkay Global

Dr. Lal PathLabs Ltd - 539524 - Closure of Trading Window

Attached

Dr. Lal Pathlabs Financials

Dr. Lal Pathlabs Technicals

EMA & SMA

Current Price
₹1,934.00
-18.3 (-0.94%)
pointer
  • Bearish Moving Average 1
  • Bullish Moving Average 15
  • 20 Day
  • ₹1,917.50
  • 50 Day
  • ₹1,867.40
  • 100 Day
  • ₹1,773.90
  • 200 Day
  • ₹1,667.10

Resistance and Support

1935.57 Pivot Speed
  • R3 2,075.90
  • R2 2,031.40
  • R1 1,991.80
  • S1 1,907.70
  • S2 1,863.20
  • S3 1,823.60

Dr. Lal Pathlabs Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-11-04 Quarterly Results
2026-07-24 Quarterly Results
2026-04-30 Audited Results & Final Dividend
2026-01-30 Quarterly Results & Interim Dividend To consider other business matters.
2025-10-31 Qtr Results, Int.Dividend & Bonus issue
Date Purpose Remarks
2026-07-30 INTERIM Rs.5.00 per share(50%)Interim Dividend
2026-06-26 FINAL Rs.4.00 per share(40%)Final Dividend
2026-02-05 INTERIM Rs.3.50 per share(35%)Third Interim Dividend
2025-11-07 INTERIM Rs.7.00 per share(70%)Second Interim Dividend
2025-08-06 INTERIM Rs.6.00 per share(60%)Interim Dividend
View Dr. Lal Pathlabs Dividend History Arrow
Date Purpose Remarks
2025-12-19 Bonus Bonus issue of equity shares in the ratio of 1:1 of Rs. 10/-.

Dr. Lal Pathlabs Shareholding Pattern

53.19%
18.79%
17.35%
7.48%
2.81%

About Dr. Lal Pathlabs

Dr. Lal PathLabs engaged in the business of running laboratories for carrying out pathological investigations of various branches of bio-chemistry, hematology, histopathology, microbiology, electrophoresis, immunochemistry, immunology, virology, cytology, View More
  • NSE Symbol
  • LALPATHLAB
  • BSE Symbol
  • 539524
  • ISIN
  • INE600L01024

Similar Stocks to Dr. Lal Pathlabs

Dr. Lal Pathlabs FAQs

Dr. Lal Pathlabs share price is ₹1,934 As on 28 September, 2026 | 13:04

The Market Cap of Dr. Lal Pathlabs is ₹32462 Cr As on 28 September, 2026 | 13:04

The P/E ratio of Dr. Lal Pathlabs is 59.9 As on 28 September, 2026 | 13:04

The PB ratio of Dr. Lal Pathlabs is 12.1 As on 28 September, 2026 | 13:04

The 52 week High & Low of Dr. Lal Pathlabs is ₹2038.6/₹1272.6 respectively As on 28 September, 2026 | 13:04

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23